-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Invivo Therapeutics Holdings Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Invivo Therapeutics Holdings Corp. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.83M, a 1% decline year-over-year.
- Invivo Therapeutics Holdings Corp. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$9.86M, a 11.3% increase year-over-year.
- Invivo Therapeutics Holdings Corp. annual Operating Income (Loss) for 2022 was -$10.7M, a 7.58% decline from 2021.
- Invivo Therapeutics Holdings Corp. annual Operating Income (Loss) for 2021 was -$9.9M, a 8.83% decline from 2020.
- Invivo Therapeutics Holdings Corp. annual Operating Income (Loss) for 2020 was -$9.1M, a 20.9% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)